Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Chronic obstructive pulmonary disease

Recruiting

Investigational

Study of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:LUNSEKIMIG

Contact Research Centre

Non-small cell lung cancer+1

Recruiting

Registered drugNo placebo

Phase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

Registered drug

A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Depemokimab

Contact Research Centre

Arteriosclerosis

Recruiting

Investigational

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational

Germany

Participants:18–64 years · 65+ years

Contact Research Centre

Acute myocardial infarction

Recruiting

Registered drugNo placebo

Study on Managing Heart Attack Risk with Icosapent Ethyl and Drug Combination for Patients at High Risk of Another Heart Attack

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Colchicine

Contact Research Centre

Squamous cell carcinoma of lung+6

Recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:BNT327

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Study comparing Rilvegostomig plus chemotherapy versus Pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Squamous cell carcinoma of head and neck

Recruiting

Registered drug

Study of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Dostarlimab

Contact Research Centre

Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

Recruiting

Investigational

Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Finerenone

Contact Research Centre

Transitional cell carcinoma

Recruiting

Registered drugNo placebo

Adjuvant Datopotamab Deruxtecan with Drug Combination in Patients with High‑Risk Muscle‑Invasive Urothelial Carcinoma

Registered drugNo placebo

Germany

Participants:18–64 years
Substances:Durvalumab

Contact Research Centre

Idiopathic pulmonary fibrosis

Recruiting

Investigational

Efficacy and Safety of Oral PIPE-791 in Adults with Idiopathic Pulmonary Fibrosis: A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study

Investigational

Germany

Participants:18–64 years · 65+ years

Contact Research Centre

Idiopathic pulmonary fibrosis

Recruiting

Investigational

Phase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis

Investigational

Germany

Participants:18–64 years · 65+ years

Contact Research Centre

Find therapies in clinical trials near you

245 trials match your criteria

Chronic obstructive pulmonary disease

Study of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD

Non-small cell lung cancer+1

Phase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC

Chronic obstructive pulmonary disease

A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Arteriosclerosis

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Acute myocardial infarction

Study on Managing Heart Attack Risk with Icosapent Ethyl and Drug Combination for Patients at High Risk of Another Heart Attack

Squamous cell carcinoma of lung+6

Study on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer

Non-small cell lung cancer

Study comparing Rilvegostomig plus chemotherapy versus Pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression

Squamous cell carcinoma of head and neck

Study of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer

Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

Transitional cell carcinoma

Adjuvant Datopotamab Deruxtecan with Drug Combination in Patients with High‑Risk Muscle‑Invasive Urothelial Carcinoma

Idiopathic pulmonary fibrosis

Efficacy and Safety of Oral PIPE-791 in Adults with Idiopathic Pulmonary Fibrosis: A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study

Idiopathic pulmonary fibrosis

Phase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.